BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 14679275)

  • 21. No Shot: US Vaccine Prices And Shortages.
    Ridley DB; Bei X; Liebman EB
    Health Aff (Millwood); 2016 Feb; 35(2):235-41. PubMed ID: 26858375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The fragility of the U.S. vaccine supply.
    Sloan FA; Berman S; Rosenbaum S; Chalk RA; Giffin RB
    N Engl J Med; 2004 Dec; 351(23):2443-7. PubMed ID: 15575064
    [No Abstract]   [Full Text] [Related]  

  • 23. Adult immunization. Summary of the National Vaccine Advisory Committee Report.
    Fedson DS
    JAMA; 1994 Oct; 272(14):1133-7. PubMed ID: 7933327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lessons learned: role of influenza vaccine production, distribution, supply, and demand--what it means for the provider.
    Orenstein WA; Schaffner W
    Am J Med; 2008 Jul; 121(7 Suppl 2):S22-7. PubMed ID: 18589064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving vaccine supply and development: who needs what?
    Pauly MV
    Health Aff (Millwood); 2005; 24(3):680-9. PubMed ID: 15886159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lessons Learned From Making and Implementing Vaccine Recommendations in the U.S.
    Walton LR; Orenstein WA; Pickering LK
    Am J Prev Med; 2015 Dec; 49(6 Suppl 4):S406-11. PubMed ID: 26297450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. United States vaccine research: a delicate fabric of public and private collaboration. National Vaccine Advisory Committee.
    Pediatrics; 1997 Dec; 100(6):1015-20. PubMed ID: 9411380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strengthening the supply of routinely administered vaccines in the United States: progress and problems--2005.
    Klein JO; Helms CM
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S145-50. PubMed ID: 16447138
    [No Abstract]   [Full Text] [Related]  

  • 30. The National Committee for Vaccines Regulation and Surveillance of Vaccine-Preventable Diseases in the Sultanate of Oman: evidence-based approach and consensus decision-making.
    Al Awaidy S
    Vaccine; 2010 Apr; 28 Suppl 1():A39-41. PubMed ID: 20412995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stockpile levels for pediatric vaccines: how much is enough?
    Jacobson SH; Sewell EC; Proano RA; Jokela JA
    Vaccine; 2006 Apr; 24(17):3530-7. PubMed ID: 16522344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccine shortages: why they occur and what needs to be done to strengthen vaccine supply.
    Klein JO; Myers MG
    Pediatrics; 2006 Jun; 117(6):2269-75. PubMed ID: 16740872
    [No Abstract]   [Full Text] [Related]  

  • 33. United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world.
    Perdue ML; Bright RA
    Vaccine; 2011 Jul; 29 Suppl 1():A48-50. PubMed ID: 21684430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of globalization on vaccine development and availability.
    Milstien JB; Kaddar M; Kieny MP
    Health Aff (Millwood); 2006; 25(4):1061-9. PubMed ID: 16835187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Australian model of immunization advice and vaccine funding.
    Nolan TM
    Vaccine; 2010 Apr; 28 Suppl 1():A76-83. PubMed ID: 20413003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccine manufacturing: challenges and solutions.
    Ulmer JB; Valley U; Rappuoli R
    Nat Biotechnol; 2006 Nov; 24(11):1377-83. PubMed ID: 17093488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should the vaccine injury compensation program be expanded to cover adults?
    Lloyd-Puryear MA; Ball LK; Benor D
    Public Health Rep; 1998; 113(3):236-42. PubMed ID: 9633868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wyeth responds to criticism.
    Stiles GM
    Md Med; 2005; 6(4):5, 7-8; author reply 8. PubMed ID: 16454430
    [No Abstract]   [Full Text] [Related]  

  • 39. Determinants of vaccine supply.
    Natl Bur Econ Res Bull Aging Health; 2011; (3):2-3. PubMed ID: 22207917
    [No Abstract]   [Full Text] [Related]  

  • 40. The U.S. vaccine supply.
    Hinman AR
    N Engl J Med; 2005 Mar; 352(10):1046-7; author reply 1046-7. PubMed ID: 15758020
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.